Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Economic value added reflects long-term benefits of investments, projects
Our understanding of financial performance and control is in a state of evolution. Traditional financial performance analysis rests heavily on the concepts of cost of capital and return on investment (ROI). Interested readers may review extended discussions of these in my previous two articles, "Cost of capital establishes benchmark for evaluation of investments," and "Financial performance metrics guide owners, managers." (April 15, 2004 Page 77 and June 15, 2004 Page 69, or go to www.ophthalmologytimes.com )
Related Videos
Related Content
